2025-02-22T23:54:57-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: Query fl=%2A&wt=json&json.nl=arrarr&q=id%3A%22irk-123456789-137976%22&qt=morelikethis&rows=5
2025-02-22T23:54:57-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: => GET http://localhost:8983/solr/biblio/select?fl=%2A&wt=json&json.nl=arrarr&q=id%3A%22irk-123456789-137976%22&qt=morelikethis&rows=5
2025-02-22T23:54:57-05:00 DEBUG: VuFindSearch\Backend\Solr\Connector: <= 200 OK
2025-02-22T23:54:57-05:00 DEBUG: Deserialized SOLR response
Generic imatinib in the treatment of chronic myeloid leukemia: two years’ experience in latvia

Generic imatinib in the treatment of chronic myeloid leukemia: two years’ experience in latvia

Background: Imatinib is tyrosine kinase inhibitor (TKI) and as a targeted anti-cancer agent has significantly changed chronic myeloid leukemia (CML) prognosis and patient survival. Currently TKI is the main therapy in CML Philadelphia chromosome-positive (Ph-positive) cases. When generics of imatini...

Full description

Saved in:
Bibliographic Details
Main Authors: Lejniece, S., Udre, I., Rivkina, A.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2017
Series:Experimental Oncology
Subjects:
Original contributions
Online Access:http://dspace.nbuv.gov.ua/handle/123456789/137976
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://dspace.nbuv.gov.ua/handle/123456789/137976

Similar Items